Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-20-054650

President sold 25,000 shares at $100.00 ($2,500,000)

  • President acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Novak Rodger President 2020-10-08 Option exercise +22,238 $14.43 $320,894 670,245 D
Novak Rodger President 2020-10-08 Sale −22,238 $100.00 $2,223,800 648,007 D
Novak Rodger President 2020-10-09 Option exercise +2,762 $14.43 $39,856 650,769 D
Novak Rodger President 2020-10-09 Sale −2,762 $100.00 $276,200 648,007 D
Derivatives
Novak Rodger President 2020-10-08 Option exercise · Stock Option (Right to Buy) −22,238 193,077 D
Novak Rodger President 2020-10-09 Option exercise · Stock Option (Right to Buy) −2,762 190,315 D
Open-market sales · 25,000 sh · avg $100.00 · $2,500,000
Loading xslF345X03/doc4.xml…